🫁 Understanding Bronchiectasis, COPD, and Aspergillosis: What Patients Need to Know

Living with a lung condition can be confusing — especially when the symptoms of bronchiectasis, COPD, and aspergillosis are so similar. This guide explains the differences, how they are diagnosed, and why many people are wrongly diagnosed (or underdiagnosed) at first.

🌬️ What Are These Conditions?

Bronchiectasis

A condition where the airways become damaged, widened, and scarred, often from past infections, immune problems, or conditions like ABPA or CPA. This makes it hard to clear mucus, leading to regular infections.

COPD (Chronic Obstructive Pulmonary Disease)

A group of conditions — including emphysema and chronic bronchitis — that cause narrowed airways and damaged air sacs. Most often caused by smoking or long-term exposure to fumes or dust.

Aspergillosis

An infection or allergic reaction caused by the fungus Aspergillus. Types include:

  • ABPA (allergic bronchopulmonary aspergillosis) — mostly in asthma or bronchiectasis

  • CPA (chronic pulmonary aspergillosis) — causes lung cavities and fungal balls

  • Aspergillus bronchitis — low-grade infection in people with bronchiectasis

🔄 Shared Symptoms

All three can cause:

Symptom Bronchiectasis COPD Aspergillosis
Chronic cough ✅ ✅ ✅
Sputum (phlegm) ✅ (often a lot) ✅ (varies) ✅ (sticky, sometimes brown)
Breathlessness ✅ ✅ ✅
Recurrent infections ✅ ✅ ✅
Fatigue ✅ ✅ ✅
Wheezing Sometimes ✅ ✅ in ABPA
Coughing blood (haemoptysis) ✅ ⚠️ ✅ (especially in CPA)

Because the symptoms are so similar, many people with aspergillosis are first told they have COPD or bronchiectasis until further tests are done.

🖥️ How Are They Diagnosed?

🧪 Tests Used

Test Helps Diagnose
Spirometry (lung function) COPD or asthma (airflow obstruction)
High-resolution CT scan Bronchiectasis, CPA, emphysema
Aspergillus IgG & IgE blood tests CPA (IgG), ABPA (IgE)
Sputum culture or PCR Finds Aspergillus or bacterial infections
Eosinophil count High in ABPA
Chest X-ray May show cavities, but CT is better

🫁 CT Scan Signs: What Do Radiologists Look For?

Feature Bronchiectasis COPD CPA / Aspergillosis
Airway shape Widened, thickened (signet-ring sign) Narrowed or normal May have overlapping bronchiectasis
Lung tissue Scarring, mucus plugging Blackened areas (emphysema) Cavities, fungal balls, fibrosis
Mucus Often present Sometimes present Mucus or fungus in airways
Other signs Tree-in-bud, cystic changes Air trapping, flattened diaphragm Thickened cavity walls, pleural changes

💨 What Are Air Trapping and Hyperinflation?

These are signs that air is getting stuck in the lungs — common in asthma, COPD, ABPA, and sometimes CPA.

🔹 Air trapping

Air gets into the lungs but can’t get out fully. You may feel like you can’t finish exhaling.

  • Seen on CT scan as dark areas during breathing out.

  • Lung function tests show high residual volume (RV).

  • Common in asthma, ABPA, bronchiectasis, and COPD.

🔹 Hyperinflation

The lungs are permanently overfilled with air, even when you’re not trying to breathe in.

  • Seen on CT/X-ray as large lungs, flattened diaphragm, and horizontal ribs.

  • Lung function shows high total lung capacity (TLC).

  • Common in emphysema, severe asthma, and ABPA.

Why it matters: Both conditions make breathing harder and less efficient, especially when active. Treatment like inhalers, antifungals, airway clearance, or biologics may help.

💊 Treatment Approaches

Treatment Bronchiectasis COPD Aspergillosis
Airway clearance physiotherapy ✅ Essential Sometimes ✅ Often vital
Antibiotics ✅ Regularly used During flares ✅ For Aspergillus bronchitis/CPA
Inhalers (bronchodilators) Sometimes helpful ✅ Core treatment ✅ In ABPA if asthma is present
Steroids In flares or ABPA ✅ Often ✅ In ABPA
Antifungals (e.g. itraconazole, voriconazole) ❌ Not routine ❌ ✅ Main treatment for CPA/ABPA
Pulmonary rehab ✅ ✅ ✅ May help fatigue/breathlessness
Oxygen Rare ✅ In advanced disease ✅ In some advanced cases

🧠 Why It’s Complicated

Many patients are misdiagnosed at first:

  • Aspergillosis can develop on top of COPD or bronchiectasis

  • A long delay in diagnosis is common

  • Some people have all three conditions, or overlapping features (e.g. COPD + ABPA)

That’s why blood tests and CT scans are so important — symptoms alone aren’t enough.

✅ Summary Table

Feature Bronchiectasis COPD Aspergillosis
Cause Infection, immune issues Smoking, pollutants Fungal allergy or infection
Airway problem Widened, mucus-filled Narrowed, damaged sacs Cavities, fungus growth or allergy
Diagnostic test CT scan Spirometry CT + Aspergillus IgG/IgE
Key treatment Clearance + antibiotics Inhalers, steroids Antifungals ± steroids

💬 What Should I Ask My Doctor?

  • Could my symptoms be due to more than one condition?

  • Have I had a CT scan and Aspergillus blood tests?

  • Should I be seen by a specialist centre (e.g. for ABPA or CPA)?

  • Am I using the right inhalers or physiotherapy?

  • Could I benefit from a sputum test or antifungal treatment?

by GAtherton

🫁 Airway Clearance in Aspergillosis: A Patient Guide

Managing mucus to breathe easier, stay healthier, and feel more in control

💡 Why Is Mucus Clearance Important?

If you’re living with a condition like chronic pulmonary aspergillosis (CPA), allergic bronchopulmonary aspergillosis (ABPA), or aspergillus bronchitis, you may experience ongoing mucus build-up in your lungs. This can:

  • Make breathing harder

  • Trap infection

  • Cause inflammation and damage

  • Trigger coughing, wheeze or breathlessness

Airway clearance techniques (ACTs) help loosen and remove this mucus, reduce chest infections, and improve daily comfort.

🗣️ “Before I started clearing mucus properly, I thought breathlessness was just something I had to live with. But it’s made a big difference.”

🔧 What Techniques Are Available?

Type Examples Purpose Needs Guidance?
Breathing exercises ACBT (Active Cycle of Breathing), huffing Loosens mucus, clears airways ✅ Yes – to be effective
Postural drainage Lying in specific positions Uses gravity to drain mucus ✅ Yes – to avoid reflux or fatigue
Devices Flutter, Acapella, Aerobika (OPEP devices) Vibrate airways + create back pressure to shift mucus ✅ Yes – to use correctly
Manual techniques Chest percussion, assisted cough Help loosen stubborn mucus ✅ Often needs a helper
Mechanical devices HFCWO (“The Vest”), IPV Used in severe or complex cases ✅ Prescribed in specialist settings

🗣️ “I use the Acapella in the mornings while the kettle boils. It’s part of my routine now – and it really helps.”

🗣️ What Do Other Patients Say?

People with aspergillosis often try more than one method before finding what works best. Here are some common reflections:

On devices:
“The flutter helped a lot once I got the angle and rhythm right – but I needed someone to show me how.”

On ACBT:
“Breathing control and huffing helped me get more up with less effort than coughing all day.”

On adapting to daily life:
“It’s about what fits into your day. If something’s too awkward or tiring, you won’t keep doing it – and that’s okay.”

On trial and error:
“It took me months to find the right technique – but now I can manage my mucus better and avoid antibiotics.”

⚠️ Should I Use a Flutter or Acapella Without Help?

Not at first. These devices are effective only if used correctly. Risks of incorrect use include:

  • Not moving mucus effectively

  • Fatigue or breathlessness

  • Worsening reflux or chest tightness

  • In rare cases, worsening of lung symptoms (e.g., if air trapping occurs)

🗣️ “I bought a device online and started using it myself – but it made me dizzy. A physio later explained I was blowing too hard.”

Always ask your respiratory team or GP for referral to a respiratory physiotherapist before starting.

📝 Patient Decision Guide: Should You Use ACTs?

✅ You may benefit if:

  • You cough up mucus daily or feel it’s “stuck”

  • You’ve had repeated chest infections

  • You live with CPA, ABPA, bronchiectasis, or aspergillus bronchitis

❌ Don’t start without guidance if:

  • You have COPD, asthma, or lung scarring

  • You’ve had haemoptysis (coughing up blood)

  • You experience dizziness, nausea, or chest pain during breathing exercises

  • You have gastric reflux or recent chest surgery

🧑‍⚕️ What Can I Start Safely at Home?

Without needing equipment, you can begin with:

  • 💧 Drink plenty of fluids – thin mucus is easier to clear

  • 🪑 Sit upright – especially when coughing or during infections

  • 🌬️ Use breathing control – calm, gentle breaths can reduce breathlessness

  • 🗣️ Try huffing – like breathing out a mirror; easier than deep coughing

🗣️ “Even on days when I’m tired, I try to stay upright and do a few rounds of breathing exercises. It’s become a habit that helps.”

🧭 Next Steps: What to Ask Your Doctor or Nurse

  • Could I see a respiratory physiotherapist to help with mucus clearance?

  • What technique is best for my condition (e.g., ABPA vs. CPA)?

  • Can I be shown how to use a flutter device or Acapella safely?

  • What should I do if I feel worse after using a technique?

🗣️ “The physio made all the difference – she explained what my lungs were doing and helped me pick something that actually worked.”

💬 Final Word

🗣️ “It’s not just about technique – it’s about what fits your life. Small steps like staying hydrated, using huffing, and getting guidance made a big difference for me.”

There’s no one-size-fits-all approach – but with the right support, airway clearance can help you take control of your lungs, reduce flare-ups, and breathe easier.

by GAtherton

Biologics and Long Term Side Effects

✅ What Are Biologics?

Biologics are targeted treatments made from living cells. They work by blocking parts of the immune system that cause inflammation — for example:

  • IL-4, IL-5, IL-13: linked to eosinophilic inflammation

  • IgE: linked to allergies and ABPA

They are not immunosuppressants like steroids or chemotherapy, but rather immune modulators.

💊 Long-Term Side Effects – What Do We Know?

👨‍⚕️ What research and experience show:

Biologic Used for Long-term safety known? Side effects most reported
Omalizumab (Xolair) Allergic asthma, ABPA 20+ years of use Injection site reactions, headache, very rare anaphylaxis
Mepolizumab (Nucala) Eosinophilic asthma, CPA 10+ years Fatigue, headache, shingles (rare), mild infections
Benralizumab (Fasenra) Severe asthma, CPA ~6–7 years Headache, pharyngitis, injection site issues
Dupilumab (Dupixent) Asthma, eczema, nasal polyps 6–8 years Eye dryness/redness, cold sores, joint pain (rare)
Tezepelumab (Tezspire) Severe asthma ~2 years Sore throat, joint pain, injection site reactions

⚠️ Possible Long-Term Concerns (but rare)

  • Infections: Some concern about slightly increased risk of herpes zoster (shingles) or respiratory viruses, but overall risk is very low compared to steroids.

  • Immunogenicity: Your body might develop antibodies to the drug over time, reducing its effect — this is more a loss of benefit, not a dangerous side effect.

  • Cancer risk: No consistent evidence linking asthma/ABPA biologics to cancer.

  • Unknowns: Because some biologics are new (e.g. tezepelumab), we don't yet have 20-year data — but so far the safety profile is reassuring.

🩺 Compared to Oral Steroids

Treatment Side Effects Over Time
Steroids (e.g. prednisolone) Weight gain, diabetes, infections, bone thinning, cataracts, adrenal suppression
Biologics Mostly minor – injection site pain, headache, mild infection risk, rare allergic reaction

So in most cases, biologics reduce the need for steroids and therefore reduce long-term harm.

💬 Patient Experience

Most patients report:

  • Improved quality of life

  • Reduced asthma/ABPA attacks

  • Fewer hospital visits

  • Very few stop due to side effects

✅ Summary

Question Answer
Do biologics have long-term side effects? Usually mild and rare; mostly injection reactions or mild infections
Are they safer than long-term steroids? Yes, especially over years
Should I be worried? Not usually — but always monitor with your team
How long have they been used? 6–20+ years, depending on the biologic, with very good safety data

by GAtherton

🛡️ How Your Care is Changing: Understanding Antimicrobial Stewardship

A guide for patients with aspergillosis and chronic lung conditions

If you're being treated for chronic pulmonary aspergillosis (CPA), ABPA, or any long-term lung condition, you might notice changes in the way doctors use antifungal and antibiotic medicines. These changes are part of a worldwide effort to tackle antimicrobial resistance (AMR) — and to make sure the right treatment is used, in the right place, for the right reason.

💬 What is Antimicrobial Stewardship?

Antimicrobial stewardship (AMS) means using antifungal and antibiotic medications responsibly, so they work better now and stay effective for the future.

It’s about:

  • Using the right medication

  • In the right place

  • For the right reason

  • At the right dose and duration

This helps ensure patients get better faster, and we all stay protected from drug-resistant infections.

🔬 What Is Antimicrobial Resistance?

Antimicrobial resistance (AMR) happens when bacteria or fungi evolve and stop responding to medicines that used to work. This makes infections:

  • Harder to treat

  • More likely to come back

  • More dangerous for people with lung or immune conditions

There are two major types:

  • Antibiotic resistance (bacteria)

  • Antifungal resistance (fungi, including Aspergillus fumigatus)

💊 Antibiotics: Broad vs Narrow Spectrum

Doctors aim to use targeted antibiotics wherever possible. Here’s how they differ:

Type Description Examples Used For
Broad-spectrum Kills a wide range of bacteria Co-amoxiclav, meropenem, ceftriaxone Sepsis, serious infections
Narrow-spectrum Targets specific bacteria Penicillin, nitrofurantoin, flucloxacillin Simple infections

🧪 Doctors may start with broad-spectrum drugs in emergencies but switch to narrow-spectrum when test results are available — this is called de-escalation.

🦠 Antifungal Resistance and Aspergillosis

People with CPA or ABPA are often treated with antifungals like:

  • Itraconazole

  • Voriconazole

  • Posaconazole

  • Isavuconazole

But fungi can develop resistance, especially when:

  • Medications are used long-term

  • Fungi are exposed to azole sprays on crops and flowers

You may inhale resistant spores from:

  • Compost, potting soil, or garden centres

  • Fresh flowers (especially imported ones)

🏥 What Might You Notice in Hospital?

✅ Shorter or targeted treatment

  • You may be on 5–7 days of antibiotics/antifungals

  • Switch from IV to tablets happens earlier once you're stable

✅ Treatment reviews

  • Your medication will be reviewed within 48–72 hours

  • Changes may be made based on lab results

✅ More testing

  • Blood, sputum, or biopsy samples help identify infections and resistance

  • Ensures you get the right treatment

✅ Specialist involvement

  • An infection or respiratory consultant may review your case if resistant infection is suspected

✅ Infection control

  • You may notice:

    • No fresh flowers

    • HEPA filters in some wards

    • Staff using extra precautions to prevent airborne infections

🏡 What Might You Notice From Your GP?

✅ More specific prescribing

  • GPs are less likely to give antibiotics “just in case”

  • More narrow-spectrum choices based on the suspected infection

✅ Diagnostic support

  • GPs may send sputum or urine samples before prescribing

  • May test your blood for antifungal levels (TDM)

✅ Home safety advice

You may be advised to:

  • Avoid indoor compost or plant pots

  • Wear FFP2/FFP3 masks when gardening

  • Keep indoor air well ventilated

🧬 New Antifungals Being Protected for Patient Use

Several antifungals are in development and being reserved just for medical use (not agriculture), including:

Drug What it is Why it matters
Rezafungin Weekly IV echinocandin Long-lasting for serious infections
Ibrexafungerp First oral alternative to azoles Trials for aspergillosis
Olorofim New class (DHODH inhibitor) Active against resistant Aspergillus
Opelconazole Inhaled antifungal Direct treatment to the lungs
Fosmanogepix Novel target Works against drug-resistant fungi

🧠 What This All Means for You

These changes are about:

  • Better outcomes — faster recovery with fewer side effects

  • Preventing resistance — protecting future treatments

  • More personalised care — based on test results and your condition

✅ What You Can Do

Action Why It Helps
Take medications exactly as prescribed Prevents underdosing and resistance
Don’t stop treatment early Even if you feel better
Ask if your treatment has been reviewed Encourages early switch or adjustment
Use a mask and gloves for gardening Reduces spore exposure
Avoid fresh flowers and compost indoors Especially in bedrooms or when unwell
Report any new or worsening symptoms Resistance may be developing
Ask about resistance testing if you’re not improving Labs can check fungal response
Stay informed and speak up You’re part of the stewardship solution

📌 In Summary: Stewardship in Action

Antimicrobial stewardship is not about doing less — it's about doing things more precisely.
It’s how your healthcare team makes sure you receive:

The right medication, in the right place, for the right reason.

🔗 Want to Learn More?

by GAtherton

💊 General Strategies to Reduce Antimicrobial Resistance in Clinical Practice

1. IV to Oral Switch (IVOS)

One of the most effective and safe interventions in antimicrobial stewardship.

🔁 Why switch from IV to oral early?

  • Reduces complications (e.g. line infections, thrombosis)

  • Lowers costs and bed-days

  • Improves patient comfort and mobility

  • Oral options (e.g. ciprofloxacin, fluconazole, linezolid) are highly bioavailable, often matching IV efficacy

✅ When is IVOS appropriate?

  • Clinical improvement seen

  • Source controlled

  • Oral route available and tolerated

  • Suitable oral alternative exists

NHS guidance: "Start smart – then focus" encourages early IVOS reviews within 48–72 hours of antibiotic initiation.

2. "Start Smart – Then Focus" (UK NHS Framework)

This key NHS antimicrobial policy includes:

  • Start Smart: Prescribe antibiotics appropriately from the beginning

  • Then Focus:

    • Review at 48–72 hours

    • Consider stop, switch, change, or continue

    • Document clearly in records

Supported by NICE guidelines and UKHSA audits

3. Shorter Duration of Therapy

For many infections, shorter courses (e.g. 5–7 days instead of 10–14) are now preferred.

Examples:

  • Community-acquired pneumonia: 5 days

  • Pyelonephritis: 7 days

  • Cellulitis: 5–7 days

This reduces resistance pressure and side effects.

4. Diagnostics-Guided Prescribing

  • Procalcitonin and CRP tests can help distinguish bacterial from viral infections

  • Rapid PCR, MRSA, or blood culture diagnostics guide targeted therapy

The aim is avoid empirical broad-spectrum antibiotics where possible.

5. Restricted Prescribing Policies

  • Certain high-risk drugs (e.g. carbapenems, vancomycin, antifungals) are restricted to ID approval

  • Antimicrobials are tiered by risk (e.g. traffic light systems) to encourage narrow-spectrum use

6. Antimicrobial Stewardship Teams (ASTs)

Multidisciplinary teams:

  • Lead on stewardship strategy

  • Audit antimicrobial use

  • Provide decision support for complex cases

  • Educate staff and update local formularies

In the NHS, stewardship is a CQUIN target (incentivised performance indicator).

7. Education and Behaviour Change

  • Mandatory AMS training for junior doctors and prescribers

  • Behavioural nudges in electronic prescribing systems (e.g. default shorter durations, alert for IVOS)

8. Surveillance and Reporting

  • ePAMS+, ESPAUR, and PHE Fingertips dashboards track:

    • Prescribing by hospital/unit

    • Resistance trends

    • Audit compliance with IVOS, duration, and documentation

9. Patient-Facing Initiatives

  • "Antibiotic Guardian" and leaflets explaining viral vs bacterial infections

  • Empowering patients to ask:

    "Do I really need antibiotics? When can I switch to tablets?"

📦 Summary Table: Key Interventions

Strategy Purpose
IV to Oral Switch Reduce IV duration, speed discharge
Review at 48–72 hrs Reassess need, de-escalate if possible
Shorter therapy courses Lower resistance pressure
Targeted diagnostics Support narrow-spectrum prescribing
Prescribing restrictions Protect last-resort antimicrobials
Stewardship teams Oversee, audit, educate
Surveillance & feedback Monitor trends, guide policy

by GAtherton

🦠 Antifungal Resistance: What It Is, How It Happens, and Why It Matters

Antifungal resistance is a growing global health threat, especially for people with lung conditions like chronic pulmonary aspergillosis (CPA) or allergic bronchopulmonary aspergillosis (ABPA). Just like bacteria can become resistant to antibiotics, fungi like Aspergillus fumigatus can develop resistance to antifungal drugs — making infections harder or even impossible to treat.

🔍 What Is Antifungal Resistance?

Antifungal resistance occurs when fungi evolve in ways that allow them to survive exposure to medications that used to kill them or stop their growth. This makes standard treatments less effective and increases the risk of:

  • Treatment failure

  • Prolonged illness

  • More severe infections

  • Increased hospital stays and costs

  • Higher death rates in vulnerable patients

🧬 How Does It Develop?

Fungi become resistant through genetic changes, often due to:

  • Long-term antifungal treatment in patients

  • Widespread environmental exposure to antifungal chemicals — especially azoles used on crops

Once resistance develops, the fungus may stop responding to key drugs like:

  • Itraconazole

  • Voriconazole

  • Posaconazole

  • Isavuconazole

These are the mainstays of treatment for aspergillosis and other serious fungal infections.

🌾 The Role of Agriculture: A Hidden Driver

Many resistant strains of Aspergillus don’t develop in people — they develop in the environment, especially in farmland and flower production areas.

Why?

The azole fungicides used on crops are chemically very similar to the azoles used in human medicine. They target the same fungal enzyme (CYP51, involved in cell wall formation). Fungi exposed repeatedly to these sprays can adapt — and the resulting resistant spores can:

  • Survive in soil, compost, and plant debris

  • Be carried on the wind

  • Be inhaled by people — especially those with weakened lungs or immune systems

High-risk areas include:

  • Grain farming (wheat, barley, maize)

  • Fruit production (apples, grapes, citrus)

  • Ornamental flowers (e.g., roses, tulips, chrysanthemums) — especially when imported or mass-grown

  • Garden centres and potting compost

🏠 Exposure at Home: Flowers, Soil, and More

People may unknowingly bring resistant Aspergillus spores into their homes through:

  • Fresh cut flowers (especially from florists using treated imports)

  • Potting compost or stored bulbs

  • Uncovered soil and plant material indoors

This is particularly dangerous for those with lung conditions, suppressed immunity, or recent surgery.

Practical tips:

  • Avoid keeping fresh flowers or pot plants in bedrooms or living areas

  • Use gloves and masks (FFP2 or FFP3) when handling soil or compost

  • Ventilate indoor spaces after gardening

💊 What’s Being Done: Medical, Policy, and Drug Development

1. Reserving drugs for clinical use

New antifungal drugs with novel mechanisms are being designed exclusively for medical use. Some are already approved or in late clinical trials:

Drug Type / Mechanism Status Notes
Rezafungin Echinocandin (IV, once-weekly) Approved 2023 (US/EU) For Candida, with long half-life
Ibrexafungerp Oral glucan synthase inhibitor Approved 2021 (US) Active against resistant Candida, in trials for Aspergillus
Oteseconazole Oral tetrazole Approved 2022 (US) Less toxicity, fewer interactions
Olorofim Pyrimidine synthesis inhibitor Late trials First in class, active against Aspergillus
Fosmanogepix GWT1 enzyme inhibitor Trials New target, good against multi-drug resistant fungi
Opelconazole Inhaled azole Trials Direct lung delivery, potential for aspergillosis

Many of these drugs are being deliberately withheld from agriculture to protect their effectiveness.

2. Policy & regulation

  • The “One Health” approach is gaining ground: it recognises the links between human, animal, and environmental health.

  • Some countries are monitoring soil and air for resistant fungi (e.g. Netherlands, UK).

  • Campaigns are underway to regulate or ban agricultural use of triazoles that drive cross-resistance.

  • Hospitals increasingly restrict fresh flowers in high-risk wards to protect immunocompromised patients.

🧭 What Needs to Happen Next

  • Tighter coordination between agricultural and medical authorities to regulate antifungal use

  • Incentives for developing safer, non-cross-reactive fungicides for farming

  • Increased global surveillance of resistant fungi in both clinical and environmental settings

  • Patient and public education about the risks and how to reduce exposure

🧠 What Patients Can Do

If you live with aspergillosis, chronic lung disease, or weakened immunity:

✅ Take your antifungal medicine exactly as prescribed
✅ Don’t stop or change treatment without medical advice
✅ Ask about resistance testing if symptoms worsen
✅ Avoid exposure to soil, compost, and fresh flowers
✅ Use respiratory protection (FFP2/FFP3 masks) in dusty or mouldy environments
✅ Advocate for better public policies on antifungal stewardship

🔗 Want to Learn More?

by GAtherton

Telecare Devices and the UK Digital Switchover: What Aspergillosis Patients and Carers Need to Know

Background By the end of 2025, traditional landline telephone networks in the UK will be phased out and replaced by digital (VoIP) systems delivered via broadband. This national "Digital Switchover" affects anyone using landline-based devices, including many telecare systems vital to people with chronic illnesses like chronic pulmonary aspergillosis (CPA), ABPA, and SAFS.

This document provides clear guidance for aspergillosis patients and carers concerned about how this change affects telecare equipment such as fall alarms, pendant buttons, and GPS trackers.

Why This Matters for Aspergillosis Patients Many people with aspergillosis rely on telecare to remain safe at home. These may include:

  • Fall detectors
  • Emergency pendant alarms
  • Door sensors
  • GPS trackers
  • Daily wellbeing check-in devices

These systems were typically connected to analogue landlines. Once the switch to digital phone lines is made, some older devices may stop working correctly unless they are upgraded or adapted.

What Changes with the Digital Switchover?

Feature Current (Analogue Landline) Future (Digital via Broadband)
Phone line works during power cuts Yes No (unless battery backup is added)
Telecare devices plug into phone socket Yes Only with compatible router or adapter
Works independently of broadband Yes No, relies on internet connection

Common Concerns and Solutions

  1. "Will my current telecare alarm still work?"
    • Possibly not. Many older alarms won't function over digital broadband lines.
    • Solution: Ask your alarm provider if your device is VoIP compatible or if they can supply a digital-ready or cellular version.
  2. "Will full fibre broadband stop my telecare from working?"
    • Not automatically, but older devices may be incompatible.
    • Solution: If switching to full fibre, ensure your telecare system can plug into the new router or ask about an analogue telephone adapter (ATA) with battery backup.
  3. "What happens during a power cut?"
    • Digital lines go down unless you have a UPS (Uninterruptible Power Supply) or the telecare device is cellular-based.
  4. "Can I upgrade to something more future-proof?"
    • Yes. Many councils and private providers now offer mobile-enabled alarms with built-in SIM cards and GPS.
    • These do not rely on landlines or home Wi-Fi.

What You Should Do Now

  1. Contact your telecare provider
    • Ask if your current device is digital-compatible.
    • Request upgrade options if needed.
  2. Speak to your broadband provider
    • Let them know you use telecare. Ask about battery backup or compatibility.
  3. Contact your local Adult Social Care team
    • Many councils are offering free or subsidised upgrades to digital or mobile telecare.
  4. Test your system
    • Before and after switching broadband providers, run a test call with your alarm provider.

Summary As the UK phases out analogue landlines, it's essential for patients and carers to act early. Ensuring your telecare system is compatible with digital broadband will help maintain your independence and safety. Monitoring your oxygen saturation may also support early detection of lung health changes.

Resources for Further Help

If you have questions or need help contacting the right services, the National Aspergillosis Centre support team can guide you.

by GAtherton

📄 Why Might My Posaconazole Levels Be Undetectable?

Understanding Antifungal Monitoring in Aspergillosis Treatment

If you’re taking posaconazole to treat Aspergillus-related conditions like ABPA (Allergic Bronchopulmonary Aspergillosis) or CPA (Chronic Pulmonary Aspergillosis), your doctor may ask for blood tests to check if the drug is reaching the right levels in your body.

Sometimes, those tests come back showing “undetectable” or “very low” levels, even when you’ve been taking the medication exactly as prescribed.

This can be worrying — but there are several common reasons this happens, and it doesn’t always mean the medicine isn’t working or that you’ve done something wrong.

❓ What Is Posaconazole?

Posaconazole is an antifungal medicine used to treat infections caused by the Aspergillus fungus. It comes in tablet, liquid, or IV forms. Most people take the tablet once a day — often for many weeks or months.

To work properly, the drug needs to reach a certain level in your bloodstream. This is why your team may request a blood test to check how well your body is absorbing it.

🔍 Reasons Your Posaconazole Levels May Be Low or Undetectable

1. Not Enough Fat in Your Diet

Posaconazole needs some fat in your meal to be absorbed properly — especially the liquid version.
Try to take it with a meal that includes:

  • Dairy (cheese, yoghurt, full-fat milk)

  • Eggs, nuts, or oily fish

  • A little olive oil or butter in cooking

Tip: Never take it on an empty stomach!

2. Other Medications or Supplements

Some medications and remedies can reduce how well posaconazole is absorbed, including:

  • Proton pump inhibitors (e.g. omeprazole, lansoprazole)

  • Antacids

  • Rifampicin

  • Herbal supplements like St John’s Wort

Let your doctor or pharmacist know about everything you take — even vitamins and over-the-counter products.

3. Timing of the Blood Test

The blood test should be taken just before your next dose (called a trough level).
If it’s taken too early (after a fresh dose), or too late (if you missed a dose), it may give a misleading result.

4. Problems with Absorption

Some medical conditions can make it harder for your body to absorb medications, including:

  • Coeliac disease

  • Crohn’s or colitis

  • Chronic diarrhoea or digestive issues

If you have any of these, your doctor may suggest an alternative form — like switching from liquid to tablet or tablet to IV.

5. Lab or Sample Error

Occasionally, there may be a problem with the blood sample — like a delay in handling, or a lab processing issue. In that case, your team may simply repeat the test.

✅ What You Can Do

✔️ Take your medicine with food (especially with fat)
✔️ Tell your team about other medications
✔️ Check which form you’re taking (tablets are usually better absorbed than the liquid)
✔️ Ask when your blood test should be done
✔️ Don’t panic if the result is low — just repeat the test with support from your team

🩺 Why This Matters

Getting the right amount of posaconazole in your body is essential to:

  • Help clear fungal infection

  • Prevent it from spreading

  • Reduce symptoms like coughing, breathlessness, and mucus

  • Avoid the risk of fungal resistance

💬 Talk to Your Healthcare Team

If you’re concerned about your levels or not feeling better, don’t stop your medication — contact your team. There may be a simple fix like adjusting your dose, changing the form of medicine, or switching how and when you take it.

📘 For more information

Visit: www.aspergillosis.org
Or speak to your GP, pharmacist, or specialist team.

by GAtherton

Article 4: Why This New Information on Biofilms Can Be Reassuring — Not Frightening

💬 A Message to Patients: Why This New Information Can Be Reassuring — Not Frightening

We understand that learning about things like biofilms, the lung microbiome, or how different bugs work together might feel a little overwhelming or even alarming. These topics are complex and unfamiliar to many.

But we want you to know: this science is already improving care for people with aspergillosis — and you don’t need to understand every detail for it to help you.

✅ Examples of How Biofilm Awareness Is Already Helping Patients

🧪 1. Combined Treatment for Coinfection

People who have both Aspergillus and Pseudomonas infections are now more likely to be:

  • Tested for both microbes

  • Given combination therapy (e.g. antifungals + inhaled antibiotics)
    This reduces the risk of persistent symptoms and lowers the chance of hospital admission.

🌬 2. Inhaled Therapies That Reach Biofilms

Doctors are now using or trialling inhaled medications that can:

  • Reach fungal and bacterial biofilms more directly

  • Work even when oral drugs can’t penetrate
    For example, inhaled colistin or tobramycin is used in bronchiectasis; inhaled antifungals (like opelconazole) are in trials for aspergillosis.

💡 3. Chest Physiotherapy and Mucus Clearance

Biofilm research has shown that many infections hide in thick mucus. So, clearing mucus isn't just for comfort — it’s a critical part of treatment.

  • More patients now receive airway clearance devices

  • Some are referred for specialist physiotherapy to support this

🧼 4. Better Infection Control in Hospital

Because we understand that biofilms form on equipment and even in hospital air systems, specialist centres like NAC use:

  • HEPA-filtered rooms

  • Strict protocols to prevent airborne contamination
    This lowers the risk of acquiring new fungal infections during hospital stays.

📊 5. More Personalised Care

Some patients now receive tailored treatment plans based on:

  • Sputum cultures that show which organisms are present

  • Whether biofilm-forming species are involved

  • Coexisting inflammation, allergies, or colonisation patterns

This is a big shift from one-size-fits-all prescriptions.

💬 Final Reassurance

These discoveries don’t mean there’s something worse going on. They mean that:

  • Doctors now understand more

  • Treatments are becoming more precise

  • We can often treat fewer times, more effectively

You're not alone — and you're not expected to keep up with every detail. This information helps your care team make better choices for you, reduce flare-ups, and improve quality of life. And that’s what really matters.

by GAtherton

📝 Article 3: When Microbes Work Together – Aspergillus, Pseudomonas, and Lung Inflammation

🤝 Not all microbes are rivals — some collaborate

Recent research shows that Aspergillus fumigatus and Pseudomonas aeruginosa can cooperate, particularly in people with weakened lungs or structural damage (e.g. from bronchiectasis, CF, or CPA).

Examples of how they interact:

  • Pseudomonas produces toxins (phenazines) that sometimes stimulate Aspergillus growth in low doses

  • Aspergillus produces substances like gliotoxin that weaken immune responses and protect both microbes

  • Both can form mixed biofilms, making them more drug-resistant and more inflammatory

⚠️ Clinical implications:

Coinfection with Aspergillus and Pseudomonas is associated with:

  • Worse lung function in CF, bronchiectasis, CPA

  • More frequent exacerbations and hospital admissions

  • Longer recovery times and lower quality of life

🧠 Why is this important for treatment?

Doctors are now:

  • Testing for multiple microbes during exacerbations

  • Using combination therapy — antifungals and antibiotics together

  • Supporting the immune system with:

    • Airway clearance

    • Nutrition

    • Steroid balancing (not too much, not too little)

🧬 New tools on the horizon:

  • Drugs that block microbial signalling (quorum sensing)

  • Microbiome profiling to predict flare-ups

  • Biofilm-dissolving agents in development

  • Inhaled antifungals under trial (e.g. opelconazole)

🌟 Final Summary: A Shift in Perspective

Old Approach New, Holistic Approach
Target a single infection Understand the whole lung ecosystem
Treat only during active infection Focus on prevention, balance, resilience
One-size-fits-all antibiotic use Tailored therapy, minimise microbiome damage
Ignore biofilms Disrupt biofilms and support mucus clearance
Fungal and bacterial issues separate Recognise synergy and co-infection

by GAtherton